Eukaryotic Expression Systems Market - By Type (MEL, COS, CHO, Insect cells, Reagents, Expression Vectors, Competent Cells) By Host Type (Cerevisiae, Filamentous Fungi, Leishamania, Baculovirus Infected Cells) By Application (Bacterial Expression System, Yeast Expression System, Insect Expression System, Mammalian Expression System) and Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
| 1. Global Eukaryotic Expression Systems Market Research Report |
| 1.1. Study Objectives |
| 1.2. Eukaryotic Expression Systems Market - Overview |
| 1.3. Reasons to Read This Report |
| 1.4. Methodology and Forecast Analysis |
| 2. Global Eukaryotic Expression Systems Market Research Report - Preface |
| 2.1. Global Eukaryotic Expression Systems Market Research Report – Detailed Scope and Definitions |
| 2.1.1. By Type |
| 2.1.2. By Host Type |
| 2.1.3. By Application |
| 2.1.4. By Region |
| 3. Global Eukaryotic Expression Systems Market Dynamics |
| 3.1. Drivers. - Macro-Economic Based, Supply Side, Demand Side and Technology Based |
| 3.2. Restraints - By Type, By Host Type, By Application and By Country |
| 3.3. Opportunities - By Type, By Host Type, By Application and By Country/Region |
| 3.4. Trends – By Type, By Host Type, By Application and By Country |
| 3.5. PEST Analysis |
| 3.6. Porters Five Rule Analysis |
| 3.7. Company’s Share Analysis (CSA) by Region or By Country |
| 3.8. Global Eukaryotic Expression Systems Market Research Report – DROTs Impact Analysis |
| 4. Global Eukaryotic Expression Systems Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031 |
| 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 4.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 4.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and 2024 to 2031 |
| 4.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 5. Global Eukaryotic Expression Systems Market, By Type, 2016 - 2020 and Forecast, 2021 - 2027 (Market Value, In USD Mn) |
| 5.1. MEL |
| 5.1.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 5.1.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.1.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 5.1.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 5.2. COS |
| 5.2.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 5.2.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.2.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 5.2.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 5.3. CHO |
| 5.3.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 5.3.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.3.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 5.3.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 5.4. Insect Cells |
| 5.4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 5.4.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.4.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 5.4.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 5.5. Reagents |
| 5.5.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 5.5.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.5.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 5.5.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 5.6. Expression Vectors |
| 5.6.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 5.6.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.6.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 5.6.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 5.7. Competent Cells |
| 5.7.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 5.7.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.7.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 5.7.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 6. Global Eukaryotic Expression Systems Market, By Host Type, 2016 - 2020 and Forecast, 2021 - 2027 (Market Value, In USD Mn) |
| 6.1. Cerevisiae |
| 6.1.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 6.1.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.1.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 6.1.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 6.2. Filamentous Fungi |
| 6.2.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 6.2.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.2.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 6.2.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 6.3. Leishamania |
| 6.3.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 6.3.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.3.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 6.3.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 6.4. Baculovirus Infected Cells |
| 6.4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 6.4.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.4.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 6.4.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 7. Global Eukaryotic Expression Systems Market, By Application, 2016 - 2020 and Forecast, 2021 - 2027 (Market Value, In USD Mn ) |
| 7.1. Bacterial Expression System |
| 7.1.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 7.1.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.1.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 7.1.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 7.2. Yeast Expression System |
| 7.2.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 7.2.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.2.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 7.2.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 7.3. Insect Expression System |
| 7.3.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 7.3.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.3.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 7.3.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 7.4. Mammalian Expression System |
| 7.4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 7.4.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.4.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 7.4.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 8. Global Eukaryotic Expression Systems Market Forecast, By Region, 2016 - 2020 and Forecast, 2021 – 2027 (Market Value, In USD Mn ) |
| 8.1. North America |
| 8.1.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 8.1.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.1.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 8.1.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 8.2. Europe |
| 8.2.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 8.2.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.2.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 8.2.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 8.3. Asia-Pacific |
| 8.3.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 8.3.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.3.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 8.3.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 8.4. Latin America |
| 8.4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 8.4.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.4.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 8.4.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 8.5. Middle East and Africa |
| 8.5.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 – 2031 Trends (USD Millions) |
| 8.5.2. Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.5.3. Incremental Market Value/Volume Opportunity between 2019 – 2023 and From 2024 to 2031 |
| 8.5.4. Market Shares Analysis in Years - 2019, 2023, 2026 and 2031 |
| 8.6. Global Eukaryotic Expression Systems Market - Opportunity Analysis Index, By Type, By Host Type, By Application and Region, 2024 - 2031 |
| 9. North America Eukaryotic Expression Systems Market Analysis, 2016 - 2020 and Forecast, 2021 - 2027 (Market Value, In USD Mn) |
| 9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 9.1.1. MEL |
| 9.1.2. COS |
| 9.1.3. CHO |
| 9.1.4. Insect Cells |
| 9.1.5. Reagents |
| 9.1.6. Expression Vectors |
| 9.1.7. Competent Cells |
| 9.2. Host Type Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 9.2.1. Cerevisiae |
| 9.2.2. Filamentous Fungi |
| 9.2.3. Leishamania |
| 9.2.4. Baculovirus Infected Cells |
| 9.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 9.3.1. Bacterial Expression System |
| 9.3.2. Yeast Expression System |
| 9.3.3. Insect Expression System |
| 9.3.4. Mammalian Expression System |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 9.4.1. U.S. |
| 9.4.2. Canada |
| 9.5. North America Eukaryotic Expression Systems Market – Market Attractiveness Index, By Type, By Host Type, By Application and Country, 2024 - 2031 |
| 9.6. Reginal Trends Analysis |
| 9.7. North America Eukaryotic Expression Systems Market Research Report - Company Profiles |
| 9.7.1. Company 1 (USA) |
| 9.7.2. Company 2 (USA) |
| 9.7.3. Company 3 (Canada) |
| 10. Europe Eukaryotic Expression Systems Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn ) |
| 10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 10.1.1. MEL |
| 10.1.2. COS |
| 10.1.3. CHO |
| 10.1.4. Insect Cells |
| 10.1.5. Reagents |
| 10.1.6. Expression Vectors |
| 10.1.7. Competent Cells |
| 10.2. Host Type Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 10.2.1. Cerevisiae |
| 10.2.2. Filamentous Fungi |
| 10.2.3. Leishamania |
| 10.2.4. Baculovirus Infected Cells |
| 10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 10.3.1. Bacterial Expression System |
| 10.3.2. Yeast Expression System |
| 10.3.3. Insect Expression System |
| 10.3.4. Mammalian Expression System |
| 10.4. Country Analysis 2016 - 2020 and Forecast 2021 - 2027 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Eukaryotic Expression Systems Market – Market Attractiveness Index, By Type, By Host Type, By Application and Country, 2024 - 2031 |
| 10.6. Reginal Trends Analysis |
| 10.7. Europe Eukaryotic Expression Systems Market Research Report - Company Profiles |
| 10.7.1. Company – 1 (Germany) |
| 10.7.2. Company – 2 (U.K) |
| 10.7.3. Company – 3 (France) |
| 11. Asia-Pacific Eukaryotic Expression Systems Market Analysis, 2016 - 2020 and Forecast, 2021 - 2027 (Market Value, In USD Mn ) |
| 11.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 11.1.1. MEL |
| 11.1.2. COS |
| 11.1.3. CHO |
| 11.1.4. Insect Cells |
| 11.1.5. Reagents |
| 11.1.6. Expression Vectors |
| 11.1.7. Competent Cells |
| 11.2. Host Type Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 11.2.1. Cerevisiae |
| 11.2.2. Filamentous Fungi |
| 11.2.3. Leishamania |
| 11.2.4. Baculovirus Infected Cells |
| 11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 11.3.1. Bacterial Expression System |
| 11.3.2. Yeast Expression System |
| 11.3.3. Insect Expression System |
| 11.3.4. Mammalian Expression System |
| 11.4. Country Analysis 2016 - 2020 and Forecast 2021 - 2027 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Eukaryotic Expression Systems Market – Market Attractiveness Index, By Type, By Host Type, By Application and Country, 2024 - 2031 |
| 11.6. Regional Trends Analysis |
| 11.7. Asia-Pacific Eukaryotic Expression Systems Market Research Report - Company Profiles |
| 11.7.1. Company – 1 (China) |
| 11.7.2. Company – 2 (India) |
| 11.7.3. Company – 3 (Japan) |
| 12. Latin America Eukaryotic Expression Systems Market Analysis, 2019 - 20223 and Forecast, 2024 – 2031 |
| 12.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 12.1.1. MEL |
| 12.1.2. COS |
| 12.1.3. CHO |
| 12.1.4. Insect Cells |
| 12.1.5. Reagents |
| 12.1.6. Expression Vectors |
| 12.1.7. Competent Cells |
| 12.2. Host Type Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 12.2.1. Cerevisiae |
| 12.2.2. Filamentous Fungi |
| 12.2.3. Leishamania |
| 12.2.4. Baculovirus Infected Cells |
| 12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 12.3.1. Bacterial Expression System |
| 12.3.2. Yeast Expression System |
| 12.3.3. Insect Expression System |
| 12.3.4. Mammalian Expression System |
| 12.4. Country Analysis 2016 - 2020 and Forecast 2021 – 2027 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Eukaryotic Expression Systems Market – Market Attractiveness Index, By Type, By Host Type, By Application and Country, 2024 - 2031 |
| 12.6. Regional Trends Analysis |
| 12.7. Latin America Eukaryotic Expression Systems Market Research Report - Company Profiles |
| 12.7.1. Company – 1 (Brazil) |
| 13. Middle East and Africa Eukaryotic Expression Systems Market Analysis, 2019 - 2023 and Forecast, 2024 – 2031 (Revenue, USD Mn ) |
| 13.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.1.1. MEL |
| 13.1.2. COS |
| 13.1.3. CHO |
| 13.1.4. Insect Cells |
| 13.1.5. Reagents |
| 13.1.6. Expression Vectors |
| 13.1.7. Competent Cells |
| 13.2. Host Type Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.2.1. Cerevisiae |
| 13.2.2. Filamentous Fungi |
| 13.2.3. Leishamania |
| 13.2.4. Baculovirus Infected Cells |
| 13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.3.1. Bacterial Expression System |
| 13.3.2. Yeast Expression System |
| 13.3.3. Insect Expression System |
| 13.3.4. Mammalian Expression System |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Eukaryotic Expression Systems Market - Market Attractiveness Index, By Type, By Host Type, By Application and Country, 2024 - 2031 |
| 13.6. Regional Trends Analysis |
| 13.7. MEA Eukaryotic Expression Systems Market Research Report - Company Profiles |
| 13.7.1. Company – 1 (GCC) |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis) |
| 14.2.1. Agilent Technologies, Inc |
| 14.2.2. Merck KGaA |
| 14.2.3. Bio-Rad Laboratories, Inc |
| 14.2.4. QIAGEN |
| 14.2.5. Promega Corporation |
| 14.2.6. Thermo Fischer Scientific, Inc. |
| 14.2.7. Takara Bio Inc. |
| 14.2.8. GenScript |
| 14.2.9. Lonza |
| 14.2.10. New England Biolabs |
| 14.2.11. Oxford Expression Technology |
| 14.2.12. LifeSensors Inc |
| 14.2.13. Proteogenix |
| 14.2.14. Synthetic Genomics Inc |
| 14.2.15. Peak Proteins Ltd |
| 14.2.16. Sino Biological Inc |
| 14.2.17. ARTES Biotechnology GmbH |
| 14.2.18. Others |
| 15. Data Collection Method and Research Approach |
| 16. Principal Presumptions and Acronyms |
Need help?
Chat with our team in a minute.